Immune-Mediated Autonomic Neuropathies following Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia.

Abhishek A MangaonkarHassan Al KhateebNarjust DumaErik K St LouisAndrew McKeonMrinal PatnaikWilliam HoganMark LitzowTaxiarchis Kourelis

Published in: Case reports in hematology (2017)

AD after SCT is a rare yet significant clinical entity. A work-up of underlying etiology should be performed. IVIG is a treatment option for these patients.

Keyphrases

stem cell transplantation
high dose
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
heart rate variability
prognostic factors
low dose
bone marrow
blood pressure